top of page
KEY PUBLICATIONS
RECENT ARTICLES IN PEER-REVIEWED JOURNALS
Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis
Itorralba, J., Brand-Arzamendi, K., Saab, G. et al. Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis. BMC Neurol 25, 136 (2025). https://doi.org/10.1186/s12883-025-04145-0
​
​Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis Kalia, L.V., Asis, A., Arbour, N. et al. Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis. Nat Rev Neurol 20, 724–737 (2024). https://doi.org/10.1038/s41582-024-01023-0
​
​
​
bottom of page